Gladstone Pharma India Private Limited, a active private limited company, was established on 01 November 2011 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24100TN2011PTC082948. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹2.33 Cr.
It upholds a compliant status. Employing 228 professional, Its leadership includes Hariharan Ramesh (Director), Pichai Chandrasekaran (Managing Director), Shanmugam Santhosh (Director). Past directors included Murali Venkatachalam, Meenakshi, Dhanasekar. It holds ₹2.30 Cr open charges and ₹1.20 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.274, Flat D, Pearl Flat, Nateshnagar, 2Nd Cross Street, Virugambakkam, Chennai, Tamil Nadu, 600092.
U24100TN2011PTC082948
082948
01 November 2011
₹2.50 Cr
₹2.33 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Gladstone Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hariharan Ramesh | Director | 02 Mar 2017 | Current |
| Pichai Chandrasekaran | Managing Director | 01 Nov 2011 | Current |
| Shanmugam Santhosh | Director | 01 Nov 2011 | Current |
| Ariyalur Suryanarayanan Ramasamy | Director | 24 Sep 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Aug 2019 | Past |
| Pramod Abcsdd | Director | 31 Oct 2018 | Past |
| Pramod Abcsdd | Director | 28 Sep 2017 | Past |
| Pramod Abcsdd | Director | 15 Apr 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Gladstone Pharma India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.42% increase. The company also saw a substantial improvement in profitability, with a 40.18% increase in profit. The company's net worth Soared by an impressive increase of 83.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Gladstone Pharma India had a public holding of 24.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹22,998,000.00
₹12,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2020 | Others | ₹2.30 Cr | Open |
| 29 Nov 2018 | Others | ₹1.20 Cr | Satisfied |
Explore comprehensive loan charge details -
Gladstone Pharma India has a workforce of 228 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Gladstone Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gladstone Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Gladstone Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Gladstone Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.
Progress on A charge with Others of Rs. 2.30 Cr registered on 30 Jan 2020 with Charge ID 100322992 was modified on 27 Oct 2020. was documented.
Progress on A charge registered on 29 Nov 2018 via Charge ID 100231972 with Others was fully satisfied on 11 Mar 2020. was documented.
A charge with Others amounted to Rs. 2.30 Cr with Charge ID 100322992 was registered on 30 Jan 2020. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 1.20 Cr with Charge ID 100231972 was registered on 29 Nov 2018. was documented.
The CIN of Gladstone Pharma India Private Limited is U24100TN2011PTC082948.
Gladstone Pharma India Private Limited is headquartered at Plot No.274, Flat D, Pearl Flat, Nateshnagar, 2Nd Cross Street, Virugambakkam, Chennai, Tamil Nadu, 600092.
Gladstone Pharma India Private Limited was incorporated on 01 November 2011.
The current directors of Gladstone Pharma India Private Limited are
The primary industry of Gladstone Pharma India Private Limited is Trade.
Gladstone Pharma India Private Limited is unlisted.
The authorized capital of Gladstone Pharma India Private Limited is ₹2.50 Cr, and the paid-up capital is ₹2.33 Cr.
The compliance status of Gladstone Pharma India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX